FISH should be performed only on tumors with a 2+ immunohistochemical score on a large tumor area in direct correlation with the HER2 immunostained slide, and a HER2/CEP17 ratio of ≥2.0 can be considered amplified. Here, ERBB2 is linked to neoplasm.